SCHEDULE 13D
Beneficial Ownership Report
Polaryx Therapeutics, Inc. Filed Acc 0001213900-26-012759
Loading xslSCHEDULE_13D_X01/primary_doc.xml…
Polaryx Therapeutics, Inc. Filed Acc 0001213900-26-012759
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…